Fulton Breakefield Broenniman Investment Activity Analysis: Q2 2026 Portfolio Changes

Fulton Breakefield Broenniman Llc's investment strategy saw notable shifts during the second quarter of 2026. The entity engaged in substantial purchases while strategically reducing or exiting certain positions.

Notable Purchases

The investor demonstrated strong buying interest, particularly evident in new and significantly increased holdings:

• JPMorgan Exchange-Traded Fund (JCPI) was newly acquired or saw a massive increase of 100.0% in shares, adding considerable weight to its portfolio.
• SPDR Series Trust (SPIP), another fund, also experienced a huge jump (+159.73%) in share count during the quarter.
• The investment firm significantly boosted its position in several other funds and stocks:
• Vanguard Tax-Managed Fund (VEA) saw an increase of approximately +13.67%.
• iShares Core Growth Rate Treasury Bond ETF (IJR) increased by about +8.26%.
• Intuitive Surgical Inc. (ISRG) added shares, increasing its portfolio allocation percentage from 0 to 0.37%, albeit with a very high change percentage of +917.33%.
• XPO, XPO Inc., increased by 100.0% in this period.

These actions suggest confidence in specific sectors or fund strategies during Q2, although the exact nature of these purchases (individual stocks vs funds) requires further analysis from the provided data points.

Significant Sales and Reductions

Conversely, Fulton Breakefield Broenniman Llc also reduced its stake in several prominent holdings:

• Berkshire Hathaway Inc. (BRK-B) experienced a substantial decrease of approximately -81.37%.
• DanaHER Corp Del (DHR) saw its stake reduced by about -77.48% in terms of share count change from the prior period.

The reduction in shares for these large-cap names indicates a strategic shift or profit-taking decision by the investor during this quarter.